Immunotherapy in Melanoma: Role of TIGIT and LAG-3 on the antitumor immune microenvironment

Melanoma, is a malignant tumor arising from melanocytes. Given the ability of melanoma cells to inactivate lymphocytes, immunotherapy in melanoma has focused on using immune checkpoint inhibitors (ICIs) to counteract immune evasion. The lymphocyte activation gene 3 (LAG-3) and the inhibitory recepto...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Gaona Neira, Geidi Catherinne, Salazar Prieto, Shanon Daniela, Rondón Lagos, Sandra Milena
Materiálatiipa:	Online
Giella:	spa
Almmustuhtton:	Universidad Pedagógica y Tecnológica de Colombia 2023
Fáttát:	Anticuerpos monoclonales Terapia antitumoral combinada punto de control inmunitario LAG-3 TIGIT células T Monoclonal antibodies T cells immune checkpoint combined antitumor therapy
Liŋkkat:	https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/15041